Therapeutic ultrasound facilitates antiangiogenic gene delivery and inhibits prostate tumor growth

Molecular Cancer Therapeutics

Volumn 6, Issue 8, 2007, Pages 2371-2382

  Duvshani Eshet, Maayan ^a   Benny, Ofra ^a   Morgenstern, Avigail ^a   Machluf, Marcelle ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; FS 069; HEMOPEXIN LIKE DOMAIN FRAGMENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; C57BL MOUSE; CANCER GROWTH; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; PROSTATE CANCER; STATISTICAL SIGNIFICANCE; ULTRASOUND;

ALBUMINS; ANGIOGENESIS INHIBITORS; ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CULTURE MEDIA, CONDITIONED; ENDOTHELIAL CELLS; FLUOROCARBONS; GENE THERAPY; HEMOPEXIN; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; PROSTATIC NEOPLASMS; TRANSCRIPTION, GENETIC; TRANSFECTION; ULTRASONIC THERAPY;

EID: 34548103794     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-07-0019     Document Type: Article

References (46)

1. Folkman J. Antiangiogenetic gene therapy. Proc Natl Acd Sci U S A 1998;95:9064-6.
2. Somia N, Verma IM. Gene therapy: trials and tribulations. Nat Rev Genet 2000;1:91-9.
3. Marshall E. Gene therapy death prompts review of adenovirus vector. Science 1999;286:2244-5.
4. Pouton CW, Seymour LW. Key issues in non-viral gene delivery. Adv Drug Deliv Rev 2001;46:187-203.
5. Lawrie A, Brisken AF, Francis SE, et al. Microbubble-enhanced ultrasound for vascular gene delivery. Gene Ther 2000;7:2023-7.
6. Taniyama Y, Tachibana K, Hiraoka K, et al. Local delivery of plasmid DNA into rat carotid artery using ultrasound. Circulation 2002;105:1233-9.
7. Duvshani-Eshet M, Machluf M. Therapeutic ultrasound optimization for gene delivery: a key factor achieving nuclear DNA localization. J Control Release 2005;108:513-28.
8. Huber PE, Pfisterer P. In vitro and in vivo transfection of plasmid DNA in the Dunning prostate tumor R3327-1 is enhanced by focused ultrasound. Gene Ther 2000;7:1516-25.
9. Hauff P, Seemann S, Reszka R, et al. Evaluation of gas-filled microparticles and sonoporation as gene delivery system: feasibility study in rodent tumor models. Radiology 2005;236:572-8.
10. Miller DL, Quddus J. Sonoporation of monolayer cells by diagnostic ultrasound activation of contrast-agent gas bodies. Ultrasound Med Biol 2000;26:661-7.
11. Miller DL, Song J. Tumor growthreduc tion and DNA transfer by cavitation-enhanced high-intensity focused ultrasound in vivo. Ultrasound Med Biol 2003;29:887-93.
12. Manome Y, Nakamura M, Ohno T, Furuhata H. Ultrasound facilitates transduction of naked plasmid DNA into colon carcinoma cells in vitro and in vivo. Hum Gene Ther 2000;11:1521-8.
13. Zarnitsyn VG, Prausnitz MR. Physical parameters influencing optimization of ultrasound-mediated DNA transfection. Ultrasound Med Biol 2004;30:527-38.
14. Ng KY, Liu Y. Therapeutic ultrasound: its application in drug delivery. Med Res Rev 2002;22:204-23.
15. Lu QL, Liang HD, Partridge T, Blomley MJ. Microbubble ultrasound improves the efficiency of gene transduction in skeletal muscle in vivo withreduced tissue damage. Gene Ther 2003;10:396-405.
16. Wang X, Liang HD, Dong B, Lu QL, Blomley MJ. Gene transfer with microbubble ultrasound and plasmid DNA into skeletal muscle of mice: comparison between commercially available microbubble contrast agents. Radiology 2005;237:224-9.
17. Miao CH, Brayman AA, Loeb KR, et al. Ultrasound enhances gene delivery of human factor IX plasmid. Hum Gene Ther 2005;16:893-905.
18. Koike H, Tomita N, Azuma H, et al. An efficient gene transfer method mediated by ultrasound and microbubbles into the kidney. J Gene Med 2005;7:108-16.
19. Inagaki H, Suzuki JI, Ogawa M, et al. Ultrasound-microbubblemediated NF-κB decoy transfection attenuates neointimal formation after arterial injury in mice. J Vasc Res 2006;43:12-8.
20. Unger EC, Hersh E, Vannan M, McCreery T. Gene delivery using ultrasound contrast agents. Echocardiography 2001;18:355-61.
21. Bello L, Lucini V, Carrabba G, et al. Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2. Cancer Res 2001;61:8730-6.
22. Kim SK, Cargioli TG, Machluf M, et al. PEX-producing human neural stem cells inhibit tumor growth in a mouse glioma model. Clin Cancer Res 2005;11:5965-70.
23. Benny O, Duvshani-Eshet M, Cargioli T, et al. Continuous delivery of endogenous inhibitors from poly(lactic-co-glycolic acid) polymeric microspheres inhibits glioma tumor growth. Clin Cancer Res 2005;11:768-76.
24. Neufeld G, Gospodarowicz D. Identification of the fibroblast growth factor receptor in human vascular endothelial cells. J Cell Pysiol 1988;136:537-42.
25. Duvshani-Eshet M, Baruch L, Kesselman E, Shimoni E, Machluf M. Therapeutic ultrasound-mediated DNA to cell and nucleus: bioeffects revealed by confocal and atomic force microscopy. Gene Ther 2006;13:163-72.
26. Joki T, Machluf M, Atala A, et al. Continuous release of endostatin from microencapsulated engineered cells for tumor therapy. Nat Biotechnol 2001;19:35-9.
27. Koopman G, Reutelingsperger CPM, Kuijten GAM, et al. Annexin V for flow cytometric detection of phosphatidylserine expression of B cells undergoing apoptosis. Blood 1994;84:1415-20.
28. Sabo E, Peskin B, Misselevich I, et al. Computer-assisted image analysis of the rat postosteonecrotic remodeled femoral head. Exp Mol Pathol 2001;71:256-64.
29. Brooks PC, Silleti S, Schalscha TLV, Freidlander M, Cheresh DA. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment withintegrin binding activity. Cell 1998;92:391-400.
30. Dittmar KM, Xie J, Hunter F, et al. Pulsed high-intensity focused ultrasound enhances systemic administration of naked DNA in squamous cell carcinoma model: initial experience. Radiology 2005;235:541-6.
31. Miller DL, Bao S, Gies RA, Thirall BD. Ultrasonic enhancement of gene transfection in murine melanoma tumors. Ultrasound Med Biol 1999;25:1425-30.
32. Duvshani-Eshet M, Machluf M. Efficient transfection of tumors facilitated by long term therapeutic ultrasound in combination with contrast agent: from in vitro to in vivo setting. Cancer Gene Ther 2007;14:306-15.
33. Rabbani SA, Harakidas P, Guo Y, et al. Synthetic inhibitor of MMP decreases tumor growth and metastases in a syngeneic model of rat prostate. Int J Cancer 2000;87:276-82.
34. Stearns M, Stearns ME. Evidence for increased activated MMP-2 expression associated withh uman prostate cancer progression. Oncol Res 1996;8:69-75.
35. Quinn DI, Henshall SM, Sutherland RL. Molecular markers of prostate cancer outcome. Eur J Cancer 2005;41:858-87.
36. Pfeifer A, Kessler T, Silletti S, Cheresh DA, Verma IM. Suppression of angiogenesis by lentiviral delivery of PEX, a non catalytic fragment of matrix metalloproteinase 2. Proc Natl Acd Sci U S A 2000;97:12227-32.
37. Duvshani-Eshet M, Adam D, Machluf M. The effects of albumincoated microbubbles in DNA delivery mediated by therapeutic ultrasound. J Control Release 2006;112:156-66.
38. Giussani C, Carrabba G, Pluderi M, et al. Local intracerebral delivery of endogenous inhibitors by osmotic minipumps effectively suppresses glioma growth in vivo. Cancer Res 2003;63:2499-505.
39. Shimamura M, Sato N, Taniyama Y, et al. Gene transfer into adult rat spinal cord using naked plasmid DNA and ultrasound microbubbles. J Gene Med 2005;7:1468-74.
40. Stewart DA, Cooper CR, Sikes RA. Changes in extracellular matrix (ECM) and ECM-associated proteins in the metastatic progression of prostate cancer. Reprod Biol Endocrinol 2004;2:2.
41. Kaliberov SA, Kaliberova LN, Stockard CR, Grizzle WE, Buchsbaum DJ. Adenovirus-mediated FLT1-targeted proapoptotic gene therapy of human prostate cancer. Mol Ther 2004;10:1059-70.
42. Raikwar SP, Temm CJ, Raikwar NS, et al. Adenoviral vectors expressing human endostatin-angiostatin and soluble Tie2: enhanced suppression of tumor growthand antiangiogenic effects in a prostate tumor model. Mol Ther 2005;12:1091-100.
43. Watanabe M, Nasu Y, Kashiwakura Y, et al. Adeno-associated virus 2-mediated intratumoral prostate cancer gene therapy: long-term maspin expression efficiently suppresses tumor growth. Hum Gene Ther 2005;16:699-710.
44. Sakakima Y, Hayashi S, Yagi Y, et al. Gene therapy for hepatocellular carcinoma using sonoporation enhanced by contrast agents. Cancer Gene Ther 2005;12:884-9.
45. ter Haar G. Therapeutic ultrasound. Eur J Ultrasound 1999;9:3-9.
46. Amabile PG, Waugh JM, Lewis TN, et al. High-efficiency endovascular gene delivery via therapeutic ultrasound. J Am Coll Cardiol 2001;37:1975-80.